The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas

Natsume, Atsushi, Arakawa, Yoshiki, Narita, Yoshitaka · Neuro-Oncology · 2023